| For: | Spartalis M, Papagianni A. Receptor activator of nuclear factor κB ligand/osteoprotegerin axis and vascular calcifications in patients with chronic kidney disease. World J Nephrol 2016; 5(1): 1-5 [PMID: 26788459 DOI: 10.5527/wjn.v5.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v5/i1/1.htm |
| Number | Citing Articles |
| 1 |
Marcin Krzanowski, Katarzyna Krzanowska, Paulina Dumnicka, Mariusz Gajda, Karolina Woziwodzka, Danuta Fedak, Tomasz Grodzicki, Jan A Litwin, Władysław Sułowicz. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification. Therapeutic Apheresis and Dialysis 2018; 22(5) doi: 10.1111/1744-9987.12681
|
| 2 |
Peng Duan, Min Yang, Meilin Wei, Jia Liu, Ping Tu. Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes. International Journal of Endocrinology 2017; 2017 doi: 10.1155/2017/8724869
|
| 3 |
Rashad Rasheed Jawad, Hasanain Khaleel Shareef, Suhayr Aesa Al-Qaysi. Correlation between Osteoprotegerin OPG Gene Polymorphisms (rs3102735 and rs2073617) and Susceptibility to Pediatric Chronic Kidney Disease in the Karbala Province. Medical Journal of Babylon 2026; 23(2) doi: 10.4103/MJBL.MJBL_1463_23
|